Multipoint targeting of the PI3K/mTOR pathway in mesothelioma

BACKGROUND: Mesothelioma is a notoriously chemotherapy-resistant neoplasm, as is evident in the dismal overall survival for patients with those of asbestos-associated disease. We previously demonstrated co-activation of multiple receptor tyrosine kinases (RTKs), including epidermal growth factor rec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zhou, S, Liu, L, Li, H, Eilers, G, Kuang, Y, Shi, S, Yan, Z, Li, X, Corson, J M, Meng, F, Zhou, H, Sheng, Q, Fletcher, J A, Ou, W-B
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2014
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4021537/
https://ncbi.nlm.nih.gov/pubmed/24762959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.220
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados